Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Consensus
Buy4.00 / 5
3 ratings · Buy 3
Price vs analyst targets
Revenue and EPS estimates
Reported
Consensus estimates
Fiscal period
FY2023Dec '23
FY2024Dec '24
FY2025Dec '25
FY2026Dec '26
FY2027Dec '27
FY2028Dec '28
FY2029Dec '29
FY2030Dec '30
Revenue (M)
782.0
810.5
844.9
0.0
0.0
4.4
5.5
25.7
Growth YoY
+20137838.7%
+3.7%
+4.2%
−100.0%
n/m
n/m
+25.0%
+368.0%
High estimate
782.0
810.5
844.9
0.0
0.0
4.4
5.5
25.7
Low estimate
782.0
810.5
844.9
0.0
0.0
4.4
5.5
25.7
Analysts
1
2
4
0
0
7
3
5
EPS, adjusted
−15.25
−0.40
−22.61
−5.05
−3.71
−3.23
−3.69
−2.08
Growth YoY
n/m
n/m
n/m
n/m
n/m
n/m
n/m
n/m
High estimate
–
–
–
−4.16
−2.43
−2.18
−3.69
−2.08
Low estimate
–
–
–
−5.57
−6.72
−4.18
−3.69
−2.08
Analysts
–
–
–
4
7
4
1
1
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
Brokers
4 firms active in the last 12 months
Firm
Analyst
Rating
Prev rating
Target
Prev target
Chg
Upside
Date
Roth Capital
–
–
–
$29.00
$19.00
+53%
+118%
Aug 21
Guggenheim
–
Buy
Buy
–
–
–
–
Aug 14
Chardan Capital
Keay Nakae
Buy
Buy
$33.00
$20.00
+65%
+148%
Jul 28
HC Wainwright & Co.
–
Buy
Buy
$18.00
$100.00
−82%
+35%
Jun 24
Latest analyst action · Page refreshed hourly; analyst feeds refreshed daily · About this data